tyrosine has been researched along with Thrombopenia in 82 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (4.88) | 18.7374 |
| 1990's | 5 (6.10) | 18.2507 |
| 2000's | 50 (60.98) | 29.6817 |
| 2010's | 21 (25.61) | 24.3611 |
| 2020's | 2 (2.44) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J; Wang, J; Xu, Y; Yan, X; Zhang, R; Zhao, J | 1 |
| Wang, J; Zou, D | 1 |
| Cios, TJ; Guvakov, D; Salamanca-Padilla, Y | 1 |
| Bernit, E; Christen, JR; Cuisset, T; Darmon, O; Ebbo, M; Grados, A; Harlé, JR; Martinez, E; Picou, L; Roumieu, V; Scandaliaris, S; Schleinitz, N; Soubrier, C | 1 |
| Dursunoglu, D; Gür, S; Sari, I; Taskoylu, O | 1 |
| Gao, C; Hu, D; Li, M; Liu, H; Wang, X; Yang, H; Zhang, Y; Zhu, Z | 1 |
| Altay, S; Ekmekci, A; Eren, M; Golcuk, Y; Gunay, E; Velibey, Y | 1 |
| Austin, D; Christie, J; de Belder, MA; Hennigan, B; Mackay, DF; Morley, R; Oldroyd, KG; Pell, JP | 1 |
| Alüzüm, H; Ede, H; Erbay, AR; Erkoç, MF; Özdemir, ZT | 1 |
| Huang, H; Ouyang, F; Peng, H; Yin, Y; Zeng, J; Zhou, X | 1 |
| Adamo, M; Ariotti, S; Costa, F; Curello, S; de Vries, T; Moschovitis, A; Valgimigli, M; White, HD; Windecker, S | 1 |
| Cao, Y; Ding, X; Gamariel, RR; Kong, Y; Li, ZY; Liu, TD; Liu, XD; Ming, X; Wang, CH; Xie, ZL; Zhao, Q | 1 |
| Carteaux, JP; Durand, M; Hacquard, M; Lecompte, T | 1 |
| Si, LY; Wang, HL; Xu, Q | 1 |
| Beiras-Fernandez, A; Jiru, P; Kowert, A; Reichart, B; Schmoeckel, M; Spannagl, M; Weis, M | 1 |
| Koulouris, S; Manolis, AS; Pastromas, S; Sakellariou, D | 1 |
| Jia, D; Li, Y; Nie, X; Yan, Z; Zhao, Y; Zhou, Y; Zhou, Z | 1 |
| Bizzarri, F; Frati, G | 1 |
| Briguori, C; Caccavale, M; D'Andrea, D; Focaccio, A; Golia, B; Librera, M; Ricciarelli, B; Tavano, D; Visconti, G | 1 |
| Ricci, Z; Ronco, C | 1 |
| Jafary, FH; Rahman, N | 1 |
| Juwana, YB; Ottervanger, JP; Suryapranata, H; van 't Hof, AW | 1 |
| Tebaldi, M; Valgimigli, M | 1 |
| Lin, X; Liu, Y; Ni, Z; Wan, X; Yang, X; Zhang, L; Zhang, Z | 1 |
| Corbi, P; Hajj-Chahine, J; Jayle, C; Tomasi, J | 1 |
| Sachithanandan, A | 1 |
| Bihan, D; Farndale, RW; Ghevaert, CJ; Hamaia, S; Hughes, CE; Jarvis, GE; Pearce, AC; Pugh, N; Rudd, CE; Ware, J; Watson, SP | 1 |
| Aster, RH; Bougie, DW; Rasmussen, M; Zhu, J | 1 |
| Balling, G; Martin, K; Neuray, M; Schreiber, C | 1 |
| Teke, D; Teke, HÜ | 1 |
| Akpınar, TS; Besısık, SK; Elcioglu, OC; Ozkok, A; Sezer, M; Tufan, F; Umman, S | 1 |
| Aster, RH; Bougie, DW; Curtis, BR; Levine, S; Lind, RN; Malik, M; Pereira, J; Wilker, PR; Wuitschick, ED | 1 |
| Carrozza, JP; Cohen, DJ; Pinto, DS; Sperling, RT; Tu, TM | 1 |
| Christopoulos, CG | 1 |
| Auer, J; Berent, R; Eber, B; Lassnig, E; Maurer, E; Weber, T | 1 |
| GENTZ, J; JAGENBURG, R; ZETTERSTROEM, R | 1 |
| Casten, R; Dunkley, S; Evans, S; Jepson, N; Lindeman, R | 1 |
| Cochran, K; DeMartini, TJ; Grassman, ED; Lewis, BE; Leya, F; O Brien, J; Steen, LH | 1 |
| Abrams, CS; Cines, DB | 1 |
| Bandiera, E; Cifaldi, L; Giliani, S; Gismondi, A; Jacobelli, J; Mazza, C; Morrone, S; Notarangelo, L; Parolini, S; Santoni, A | 1 |
| Ardissino, D; Brennan, DM; Buratti, S; Menozzi, A; Merlini, PA; Moliterno, DJ; Rossi, M; Topol, EJ | 1 |
| Angioi, M; Carteaux, JP; de Maistre, E; Fohlen-Walter, A; Lecompte, T; Moulin, F; Mulot, A; Sghaier, M | 1 |
| Aster, RH; Bougie, DW; Curtis, BR | 1 |
| Aster, RH | 1 |
| Cummings, CL; Drachman, JG; Gandhi, MJ; Glembotsky, AC; Heller, PG; Kornblihtt, LI; Marta, RF; Molinas, FC; Pirola, CJ | 1 |
| Erkoc, R; Eryonucu, B; Tuncer, M | 1 |
| Bosco, A; Dunkley, S; Kidson-Gerber, G | 1 |
| Shanmugam, G | 1 |
| Huxtable, LM; Rakkar, AN; Tafreshi, MJ | 1 |
| Aster, RH; Bougie, DW; Chong, BH; Curtis, BR; Dunkley, S; Greinacher, A; Warkentin, TE | 1 |
| Dorsch, MP; Montague, D; Patterson, C; Rodgers, JE | 1 |
| Braun, S; Dietrich, W; Eicken, A; Kostolny, M; Lange, R; Schreiber, C | 1 |
| Demirkan, B; Guray, U; Guray, Y; Korkmaz, S | 1 |
| Köprülü, D; Tuhta, AG; Yeşildağ, O | 1 |
| Clofent-Sanchez, G; Coste, P; Harizi, H; Jais, C; Nurden, A; Nurden, P | 1 |
| Banerjee, S; Chen, S; Ho, C; Labinaz, M; Martin, J; Mensinkai, S | 1 |
| Agnelli, D; Ottani, F | 1 |
| Carteaux, JP; Roux, S; Steiner, B | 1 |
| Bakhos, M; Fareed, J; Jeske, WP; Lewis, BE; Leya, F; Walenga, JM; Wallis, DE | 1 |
| Chanu, B | 1 |
| Tcheng, JE | 1 |
| Desai, M; Lucore, CL | 1 |
| Blankenship, JC; Dasgupta, H; Demko, SL; Frey, CM; Menapace, FJ; Wood, GC | 1 |
| Jang, IK; Sabatine, MS | 1 |
| Ballmaier, M; Cremer, M; Folman, CC; Schulze, H; Strauss, G; Welte, K | 1 |
| Blankenship, JC; Iliadis, EA | 1 |
| Chap, H; Gratacap, MP; Hérault, JP; Herbert, JM; Payrastre, B; Plantavid, M; Ragab, A; Savi, P; Viala, C | 1 |
| Hetzer, R; Koster, A; Kuppe, H; Loebe, M; Mertzlufft, F | 1 |
| Bach, F; Fischer, T; Hetzer, R; Koster, A; Kukucka, M; Kuppe, H; Loebe, M; Mertzlufft, F; Meyer, O | 1 |
| Ochs, HD; Oda, A | 1 |
| Bassand, JP | 1 |
| Vernon, SM | 1 |
| Bertrand, M; Cohen, DJ; Cohen, EA; Demopoulos, L; DiBattiste, PM; Grines, CL; Herrmann, HC; Moliterno, DJ; Neumann, FJ; Powers, ER; Stone, GW; Topol, EJ | 1 |
| Kurz, HI; Lasala, JM; Taniuchi, M | 1 |
| Caputo, RP; Esente, P; Giambartolomei, A; Reger, M; Simons, A; Wagner, S | 1 |
| Corno, A; Horisberger, J; Marty, B; Mueller, X; von Segesser, LK | 1 |
| Bauer, M; Fischer, T; Hetzer, R; Koster, A; Krabatsch, T; Kukucka, M; Kuppe, H; Meyer, O | 1 |
| Bertrand, M; Cohen, DJ; Cohen, EA; Cohen, M; DiBattiste, PM; Grines, CL; Herrmann, HC; Moliterno, DJ; Moses, JW; Neumann, FJ; Powers, ER; Stone, GW; Topol, EJ; Wolski, K | 1 |
| Vinazzer, H | 1 |
| Halvorsen, S; Kvittingen, EA; Steen-Johnsen, J; Søvik, O | 1 |
| Bickel, H; Lutz, P; Nützenadel, W | 1 |
| Ginsburg, AD; Godwin, HA | 1 |
22 review(s) available for tyrosine and Thrombopenia
| Article | Year |
|---|---|
Tirofiban-induced thrombocytopenia.
Topics: Acute Coronary Syndrome; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine | 2023 |
Year in review 2008: Critical Care--nephrology.
Topics: Acute Kidney Injury; Anti-Infective Agents; Anticoagulants; Critical Care; Humans; Intensive Care Units; Nephrology; Platelet Aggregation Inhibitors; Protein C; Recombinant Proteins; Renal Replacement Therapy; Thrombocytopenia; Tirofiban; Tyrosine; Water-Electrolyte Balance | 2009 |
Tirofiban for myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Dose-Response Relationship, Drug; Electrocardiography; Hemorrhage; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine | 2010 |
Safety evaluation of tirofiban.
Topics: Abciximab; Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Clopidogrel; Double-Blind Method; Drug Resistance; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Incidence; Multicenter Studies as Topic; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Thrombocytopenia; Ticlopidine; Tirofiban; Tyrosine | 2010 |
Severe thrombocytopenia and alveolar hemorrhage represent two types of bleeding tendency during tirofiban treatment: case report and literature review.
Topics: Acute Coronary Syndrome; Aged; Hemorrhage; Humans; Male; Middle Aged; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Pulmonary Alveoli; Thrombocytopenia; Tirofiban; Tyrosine | 2012 |
Combination platelet glycoprotein IIb/IIIa receptor and lepirudin administration during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
Topics: Abciximab; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Drug Therapy, Combination; Eptifibatide; Female; Fibrinolytic Agents; Heparin; Hirudins; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Thrombocytopenia; Tirofiban; Tyrosine | 2003 |
[Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].
Topics: Abciximab; Administration, Oral; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Controlled Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Drug Therapy, Combination; Electrocardiography; Emergencies; Eptifibatide; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Stents; Syndrome; Thrombocytopenia; Thrombolytic Therapy; Time Factors; Tirofiban; Tyrosine | 2003 |
Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors.
Topics: Abciximab; Animals; Antibodies, Monoclonal; Antibody Specificity; Clinical Trials as Topic; Epitopes; Eptifibatide; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Mice; Myocardial Infarction; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Fusion Proteins; Thrombocytopenia; Tirofiban; Tyrosine | 2004 |
Practical approach to the diagnosis and management of thrombocytopenia associated with tirofiban treatment.
Topics: Aged; Disease Management; Female; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine | 2004 |
Thrombocytopenia resulting from sensitivity to GPIIb-IIIa inhibitors.
Topics: Abciximab; Antibodies, Monoclonal; Diagnosis, Differential; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Immunoglobulin G; Ligands; Models, Chemical; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Thrombocytopenia; Tirofiban; Tyrosine | 2004 |
Immune thrombocytopenia caused by glycoprotein IIb/IIIa inhibitors.
Topics: Abciximab; Antibodies, Monoclonal; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine | 2005 |
Tirofiban and emergency coronary surgery.
Topics: Acute Disease; Administration, Oral; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Emergencies; Humans; Infusions, Intravenous; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Hemorrhage; Thrombocytopenia; Tirofiban; Tyrosine | 2005 |
Frequency and management of thrombocytopenia with the glycoprotein IIb/IIIa receptor antagonists.
Topics: Abciximab; Adrenal Cortex Hormones; Antibodies, Monoclonal; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Immunoglobulins, Intravenous; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prevalence; Thrombocytopenia; Tirofiban; Tyrosine | 2006 |
Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors.
Topics: Abciximab; Antibodies, Monoclonal; Autoantibodies; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine | 2006 |
Meta-analysis of clinical efficacy and bleeding risk with intravenous glycoprotein IIb/IIIa antagonists for percutaneous coronary intervention.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Bleeding Time; Eptifibatide; Female; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Reoperation; Thrombocytopenia; Tirofiban; Treatment Outcome; Tyrosine | 2007 |
Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment.
Topics: Eptifibatide; Hemorrhage; Humans; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Risk Factors; Survival Rate; Thrombocytopenia; Tirofiban; Tyrosine | 2000 |
Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis.
Topics: Abciximab; Antibodies, Monoclonal; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Thrombocytopenia; Tirofiban; Tyrosine | 2000 |
The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease.
Topics: Abciximab; Acetates; Acute Disease; Administration, Oral; Alanine; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Benzamidines; Coronary Disease; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Oximes; Peptides; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Randomized Controlled Trials as Topic; Stents; Syndrome; Thrombocytopenia; Thrombolytic Therapy; Tirofiban; Tyrosine | 2000 |
Wiskott-Aldrich syndrome protein and platelets.
Topics: Blood Platelets; Female; Genetic Linkage; Humans; Male; Mutation; Phenotype; Phosphorylation; Proteins; Thrombocytopenia; Tyrosine; Wiskott-Aldrich Syndrome; Wiskott-Aldrich Syndrome Protein; X Chromosome | 2000 |
Low-molecular-weight heparin and other antithrombotic agents in the setting of a fast-track revascularization in unstable coronary artery disease.
Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clinical Trials as Topic; Combined Modality Therapy; Diabetes Complications; Drug Therapy, Combination; Eptifibatide; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Hirudin Therapy; Hirudins; Humans; Immunoglobulin Fab Fragments; Myocardial Revascularization; Oligosaccharides; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Randomized Controlled Trials as Topic; Recombinant Proteins; Risk Factors; Thrombocytopenia; Thrombosis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2000 |
Glycoprotein IIb/IIIa antagonists and low-molecular weight heparin in acute coronary syndromes.
Topics: Abciximab; Angina, Unstable; Antibodies, Monoclonal; Coronary Artery Bypass; Dalteparin; Enoxaparin; Eptifibatide; Fibrinolytic Agents; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Nadroparin; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Thrombosis; Tirofiban; Transaminases; Tyrosine | 2001 |
Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
Topics: Abciximab; Ancrod; Antibodies, Monoclonal; Anticoagulants; Arginine; Cardiopulmonary Bypass; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Combinations; Drug Hypersensitivity; Factor Xa Inhibitors; Hemodilution; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Humans; Immunoglobulin Fab Fragments; Perfusion; Pipecolic Acids; Platelet Aggregation Inhibitors; Protamines; Sulfonamides; Thrombocytopenia; Thrombophilia; Thrombosis; Tirofiban; Tyrosine | 2001 |
10 trial(s) available for tyrosine and Thrombopenia
| Article | Year |
|---|---|
Routine early versus deferred provisional tirofiban treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Drug Administration Schedule; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Postoperative Complications; Thrombocytopenia; Tirofiban; Treatment Outcome; Tyrosine | 2013 |
Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial.
Topics: Acute Coronary Syndrome; Aged; Buffers; Chi-Square Distribution; Citrates; Double-Blind Method; Drug Compounding; Drug Stability; Drugs, Generic; Female; Heparin; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Odds Ratio; Phosphates; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; Thrombocytopenia; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2016 |
Efficacy and safety of tirofiban in high-risk patients with non-ST-segment elevation acute coronary syndromes.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Biomarkers; Creatine Kinase, MB Form; Double-Blind Method; Electrocardiography; Female; Heart Diseases; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Thrombocytopenia; Time Factors; Tirofiban; Treatment Outcome; Troponin I; Tyrosine | 2009 |
Comparison of bivalirudin monotherapy versus unfractionated heparin plus tirofiban in patients with diabetes mellitus undergoing elective percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Coronary Artery Disease; Diabetes Mellitus; Drug Therapy, Combination; Female; Hemorrhage; Heparin; Hirudins; Humans; Male; Myocardial Infarction; Peptide Fragments; Platelet Aggregation Inhibitors; Prospective Studies; Recombinant Proteins; Retreatment; Thrombocytopenia; Tirofiban; Tyrosine | 2009 |
Use of lepirudin during percutaneous vascular interventions in patients with heparin-induced thrombocytopenia.
Topics: Abciximab; Angioplasty, Balloon; Antibodies, Monoclonal; Anticoagulants; Drug Therapy, Combination; Eptifibatide; Female; Heparin; Hirudins; Humans; Immunoglobulin Fab Fragments; Male; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Recombinant Proteins; Thrombocytopenia; Tirofiban; Treatment Outcome; Tyrosine | 2003 |
Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting.
Topics: Abciximab; Adult; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Blood Transfusion; Combined Modality Therapy; Coronary Stenosis; Double-Blind Method; Female; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Incidence; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Risk Factors; Stents; Thrombocytopenia; Tirofiban; Treatment Outcome; Tyrosine | 2004 |
[Inhibitors of GPIIb/IIIa platelet receptors].
Topics: Abciximab; Acetates; Antibodies, Monoclonal; Cerebrovascular Disorders; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine | 1999 |
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombocytopenia; Tirofiban; Tyrosine | 2001 |
Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population.
Topics: Abciximab; Antibodies, Monoclonal; Clopidogrel; Coronary Disease; Coronary Thrombosis; Eptifibatide; Exanthema; Female; Gastrointestinal Diseases; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Neutropenia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombocytopenia; Ticlopidine; Tirofiban; Tyrosine | 2001 |
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial.
Topics: Abciximab; Acute Disease; Aged; Antibodies, Monoclonal; Blood Vessel Prosthesis Implantation; Coronary Artery Disease; Disease-Free Survival; Double-Blind Method; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Postoperative Hemorrhage; Prospective Studies; Severity of Illness Index; Stents; Thrombocytopenia; Tirofiban; Treatment Outcome; Tyrosine | 2002 |
50 other study(ies) available for tyrosine and Thrombopenia
| Article | Year |
|---|---|
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1B Inhibition Promotes Megakaryocyte Polyploidization and Platelet Production.
Topics: Animals; Blood Platelets; Cyclin D1; Megakaryocytes; Mice; Phosphorylation; Thrombocytopenia; Tyrosine | 2023 |
An Anti-Coagulation Conundrum: Implantation of Total Artificial Heart in a Patient with Heparin-Induced Thrombocytopenia Type II.
Topics: Anticoagulants; Cardiopulmonary Bypass; Heart, Artificial; Heparin; Humans; Platelet Aggregation Inhibitors; Thrombocytopenia; Tirofiban; Tyrosine | 2017 |
[Long-lasting thrombocytopenia induced by glycoprotein IIb/IIIa inhibitor].
Topics: Aged; Humans; Male; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Severity of Illness Index; Thrombocytopenia; Time Factors; Tirofiban; Tyrosine | 2017 |
Tirofiban-induced acute profound thrombocytopenia after primary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Biomarkers; Erythrocyte Transfusion; Fibrinolytic Agents; Humans; Inferior Wall Myocardial Infarction; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Platelet Transfusion; Severity of Illness Index; Thrombocytopenia; Tirofiban; Treatment Outcome; Tyrosine | 2013 |
Tirofiban-induced acute profound thrombocytopenia: what is the optimal approach to treatment?
Topics: Adult; Humans; Immunoglobulins, Intravenous; Male; Platelet Aggregation Inhibitors; Platelet Count; Thrombocytopenia; Tirofiban; Treatment Outcome; Tyrosine | 2015 |
High-bolus dose tirofiban compared with abciximab in primary percutaneous coronary intervention: a propensity score-matched outcome study.
Topics: Abciximab; Aged; Antibodies, Monoclonal; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Propensity Score; Survival Analysis; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine | 2015 |
Tirofiban induced anemia without thrombocytopenia.
Topics: Aged; Anemia; Coronary Angiography; Coronary Stenosis; Fibrinolytic Agents; Humans; Male; Stents; Thrombocytopenia; Tirofiban; Tyrosine | 2015 |
Diffused alveolar hemorrhage: A rare and severe complication of tirofiban-induced thrombocytopenia.
Topics: Aged; Coronary Occlusion; Hemorrhage; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Thrombocytopenia; Tirofiban; Tyrosine | 2016 |
A Naphthalenic Derivative ND-1 Inhibits Thrombus Formation by Interfering the Binding of Fibrinogen to Integrin
Topics: Abciximab; Animals; Antibodies, Monoclonal; Cardiovascular Diseases; Disease Models, Animal; Eptifibatide; Fibrinogen; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Integrin alpha2; Integrin beta3; Mice; Naphthalenes; Peptides; Platelet Aggregation; Rats; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine | 2016 |
Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade.
Topics: Anticoagulants; Cardiopulmonary Bypass; Drug Therapy, Combination; Factor VIIa; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Postoperative Hemorrhage; Reoperation; Thrombocytopenia; Tirofiban; Tyrosine | 2008 |
[Case report of acute severe thrombocytopenia induced by tirofiban].
Topics: Acute Disease; Humans; Male; Middle Aged; Thrombocytopenia; Tirofiban; Tyrosine | 2008 |
Acute profound thrombocytopenia after treatment with tirofiban and off-pump coronary artery bypass grafting.
Topics: Acute Coronary Syndrome; Acute Disease; Angina, Unstable; Coronary Angiography; Coronary Artery Bypass, Off-Pump; Follow-Up Studies; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Platelet Transfusion; Postoperative Complications; Preoperative Care; Risk Assessment; Severity of Illness Index; Thrombocytopenia; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine | 2009 |
First report of tirofiban-induced anemia (found in combination with severe thrombocytopenia).
Topics: Acute Disease; Anemia; Angioplasty, Balloon, Coronary; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Male; Middle Aged; Platelet Aggregation Inhibitors; Severity of Illness Index; Thrombocytopenia; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2009 |
Acute profound thrombocytopenia after treatment with tirofiban and off-pump coronary artery bypass grafting: is there a paradox?
Topics: Acute Coronary Syndrome; Acute Disease; Cardiopulmonary Bypass; Coronary Artery Bypass, Off-Pump; Humans; Metabolic Clearance Rate; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Premedication; Risk Factors; Thrombocytopenia; Tirofiban; Tyrosine | 2009 |
Vanishing platelets: rapid and extreme tirofiban-induced thrombocytopenia after percutaneous coronary intervention for acute myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Transfusion; Renal Insufficiency; Severity of Illness Index; Thrombocytopenia; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2010 |
Non-ST-segment elevation myocardial infarction in a patient with essential thrombocythemia treated with glycoprotein IIb/IIIa inhibitor: a case report.
Topics: Electrocardiography; Enzyme Inhibitors; Humans; Hydroxyurea; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine | 2011 |
Successful surgical management of massive pulmonary embolism during the second trimester in a parturient with heparin-induced thrombocytopenia.
Topics: Adult; Anticoagulants; Cardiopulmonary Bypass; Echocardiography, Transesophageal; Embolectomy; Enoxaparin; Female; Fondaparinux; Heart Arrest, Induced; Heparin; Humans; Infant, Newborn; Live Birth; Male; Polysaccharides; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Second; Pulmonary Embolism; Thrombocytopenia; Tirofiban; Treatment Outcome; Tyrosine; Venous Thrombosis; Warfarin | 2010 |
Pulmonary embolectomy in heparin-induced thrombocytopenia and thrombosis? Safety of heparin use.
Topics: Anticoagulants; Cardiopulmonary Bypass; Embolectomy; Enoxaparin; Female; Fondaparinux; Heart Arrest, Induced; Heparin; Humans; Polysaccharides; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Second; Pulmonary Embolism; Risk Assessment; Thrombocytopenia; Tirofiban; Treatment Outcome; Tyrosine; Ultrasonography; Venous Thrombosis; Warfarin | 2010 |
A role for adhesion and degranulation-promoting adapter protein in collagen-induced platelet activation mediated via integrin α(2) β(1).
Topics: Adaptor Proteins, Signal Transducing; Animals; Blood Platelets; Carrier Proteins; CD36 Antigens; Collagen; Immunoglobulin Variable Region; Integrin alpha2beta1; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptides; Phospholipase C gamma; Phosphorylation; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Pseudopodia; Splenomegaly; Thrombocytopenia; Thromboxane A2; Thromboxane B2; Time Factors; Tyrosine | 2012 |
Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin.
Topics: Animals; Antibodies; CHO Cells; Cricetinae; Cricetulus; Eptifibatide; Humans; Ligands; Mice; Mice, Inbred BALB C; Models, Biological; Oligopeptides; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein Conformation; Rats; Substrate Specificity; Thrombocytopenia; Tirofiban; Tyrosine | 2012 |
Two consecutive open heart operations in a small child with heparin-induced thrombocytopenia type II using anticoagulation with heparin and tirofiban.
Topics: Anticoagulants; Body Size; Cardiac Surgical Procedures; Drug Therapy, Combination; Heart Septal Defects; Heparin; Humans; Infant; Male; Platelet Aggregation Inhibitors; Thrombocytopenia; Tirofiban; Tyrosine | 2012 |
Profound thrombocytopenia related with tirofiban: will it be enough to only stop medicine?
Topics: Acute Coronary Syndrome; Aged, 80 and over; Angioplasty, Balloon, Coronary; Female; Humans; Immunoglobulins, Intravenous; Platelet Count; Thrombocytopenia; Time Factors; Tirofiban; Tyrosine | 2013 |
Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa.
Topics: Acute Disease; Aged; Autoantibodies; Calcium; Case-Control Studies; Cross Reactions; Epitopes; Eptifibatide; Female; Humans; Ligands; Male; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine | 2002 |
Thrombocytopenia following treatment with platelet glycoprotein IIb/IIIa inhibitors.
Topics: Abciximab; Antibodies, Monoclonal; Autoantibodies; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine | 2003 |
TYROSINEMIA.
Topics: Acid-Base Equilibrium; Amino Acid Metabolism, Inborn Errors; Biochemical Phenomena; Biochemistry; Blood; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Therapy; Fanconi Syndrome; Genetics, Medical; Humans; Infant; Infant, Newborn; Kidney Diseases; Kidney Function Tests; Kidney Tubules; Liver Cirrhosis; Liver Function Tests; Pathology; Pigmentation Disorders; Prognosis; Proteinuria; Radiography; Rickets; Thrombocytopenia; Tyrosine; Tyrosinemias; Vitamin D; Water-Electrolyte Balance | 1965 |
Evidence of platelet activation due to tirofiban-dependent platelet antibodies: double trouble.
Topics: Aged; Antibodies; Blood Platelets; Flow Cytometry; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Serotonin; Thrombocytopenia; Time Factors; Tirofiban; Tyrosine | 2003 |
Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect.
Topics: Actins; Antibodies; cdc42 GTP-Binding Protein; Child; Child, Preschool; Chromosomes, Human, X; Genetic Linkage; Humans; In Vitro Techniques; Infant; Interleukin-2; Killer Cells, Natural; Phosphorylation; Proteins; Receptors, IgG; Thrombocytopenia; Tyrosine; Wiskott-Aldrich Syndrome; Wiskott-Aldrich Syndrome Protein | 2004 |
Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation.
Topics: Adolescent; Adult; Alleles; Amino Acid Motifs; Blood Platelet Disorders; Blood Platelets; Blotting, Western; Core Binding Factor Alpha 2 Subunit; DNA; DNA Primers; DNA-Binding Proteins; Electrophoresis, Polyacrylamide Gel; Exons; Family Health; Female; Flow Cytometry; Frameshift Mutation; Gene Expression Regulation; Genetic Predisposition to Disease; Germ-Line Mutation; Heterozygote; Humans; Immunoblotting; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Genetic; Mutation; Pedigree; Phosphorylation; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins; Receptors, Cytokine; Receptors, Thrombopoietin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Thrombocytopenia; Thrombopoietin; Transcription Factors; Tyrosine | 2005 |
Repetitive profound thrombocytopenia after treatment with tirofiban: a case report.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Drug Administration Schedule; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombocytopenia; Ticlopidine; Tirofiban; Tyrosine | 2004 |
Delayed tirofiban-induced thrombocytopenia: two case reports.
Topics: Aged; Aged, 80 and over; Antibodies; Anticoagulants; Blood Platelets; Echocardiography; Enzyme-Linked Immunosorbent Assay; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Count; Platelet Transfusion; Thrombocytopenia; Time Factors; Tirofiban; Tyrosine | 2005 |
Abciximab-associated thrombocytopenia after previous tirofiban-related thrombocytopenia.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Artery Disease; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine | 2006 |
Use of heparin upon reoperation in a pediatric patient with heparin-induced thrombocytopenia after disappearance of antibodies.
Topics: Antibodies; Anticoagulants; Aprotinin; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child; Drug Therapy, Combination; Heart Valve Prosthesis Implantation; Hemostatics; Heparin; Hirudins; Humans; Male; Mitral Valve; Phenprocoumon; Platelet Aggregation Inhibitors; Platelet Factor 4; Recombinant Proteins; Reoperation; Thrombocytopenia; Tirofiban; Tyrosine; Ventricular Outflow Obstruction | 2006 |
Differential diagnosis and management of acute profound thrombocytopenia by tirofiban: a case report.
Topics: Acute Disease; Diagnosis, Differential; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine | 2006 |
Tirofiban-associated acute thrombocytopenia.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Coronary Stenosis; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Stents; Thrombocytopenia; Tirofiban; Tyrosine | 2006 |
A case of profound and prolonged tirofiban-induced thrombocytopenia and its correction by intravenous immunoglobulin G.
Topics: Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Thrombocytopenia; Tirofiban; Tyrosine | 2007 |
[Acute profound thrombocytopenia associated with tirofiban: clinical approach to diagnosis and therapeutic management].
Topics: Acute Disease; Aged; Female; Humans; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine | 2008 |
Ro 44-9883, a new non-peptidic GPIIb-GPIIIa antagonist prevents platelet loss in a guinea pig model of extracorporeal circulation.
Topics: Acetates; Adenosine Diphosphate; Amino Acid Sequence; Animals; Extracorporeal Circulation; Guinea Pigs; Hemodynamics; Heparin; Molecular Sequence Data; Oligopeptides; Platelet Aggregation; Platelet Count; Platelet Membrane Glycoproteins; Thrombocytopenia; Tyrosine | 1993 |
Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in patients with HIT.
Topics: Abciximab; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Anticoagulants; Antithrombins; Arginine; Blood Platelets; Drug Therapy, Combination; Female; Heparin; Hirudin Therapy; Humans; Immunoglobulin Fab Fragments; Male; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides; Thrombocytopenia; Tirofiban; Tyrosine | 1999 |
Uneventful use of tirofiban as an adjunct to coronary stenting in a patient with a history of abciximab-associated thrombocytopenia 10 months earlier.
Topics: Abciximab; Antibodies, Monoclonal; Coronary Vessels; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Thrombocytopenia; Tirofiban; Tyrosine | 2000 |
Defective c-Mpl signaling in the syndrome of thrombocytopenia with absent radii.
Topics: Blood Platelets; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Interleukin-11; Janus Kinase 2; Male; Neoplasm Proteins; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Radius; Receptors, Cytokine; Receptors, Thrombopoietin; Signal Transduction; Thrombocytopenia; Thrombopoietin; Tyrosine | 1998 |
Platelets and coronary intervention: some practical precautions.
Topics: Abciximab; Antibodies, Monoclonal; Coronary Disease; Drug Monitoring; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Incidence; Male; Peptides; Platelet Aggregation Inhibitors; Prognosis; Risk Assessment; Thrombocytopenia; Tirofiban; Tyrosine | 2000 |
FcgammaRIIA requires a Gi-dependent pathway for an efficient stimulation of phosphoinositide 3-kinase, calcium mobilization, and platelet aggregation.
Topics: Adenosine Diphosphate; Adrenergic alpha-Agonists; Anticoagulants; Antigens, CD; Blood Platelets; Calcium Signaling; Dose-Response Relationship, Drug; Enzyme Activation; Epinephrine; GTP-Binding Proteins; Heparin; Humans; Isoenzymes; Phosphatidylinositol 3-Kinases; Phosphatidylinositol Phosphates; Phospholipase C gamma; Phosphorylation; Platelet Aggregation; Receptors, Adrenergic, alpha-2; Receptors, IgG; Receptors, Purinergic P2; Signal Transduction; Thrombocytopenia; Type C Phospholipases; Tyrosine | 2000 |
Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant.
Topics: Cardiopulmonary Bypass; Drug Therapy, Combination; Female; Heart Valve Prosthesis Implantation; Heparin; Hirudins; Humans; Kidney Function Tests; Middle Aged; Mitral Valve; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Care; Prosthesis Failure; Recombinant Proteins; Reoperation; Thrombocytopenia; Tirofiban; Tyrosine | 2000 |
Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban.
Topics: Adult; Aged; Anticoagulants; Blood Platelets; Cardiopulmonary Bypass; Female; Fibrin Fibrinogen Degradation Products; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Renal Insufficiency; Thrombocytopenia; Tirofiban; Tyrosine | 2001 |
Adjunctive therapies in the cath lab. Use of combination glycoprotein IIb/IIIa inhibitor and direct thrombin inhibitor drugs to support percutaneous coronary stent placement in a patient with renal insufficiency and heparin-induced thrombocytopenia.
Topics: Aged; Aged, 80 and over; Anticoagulants; Combined Modality Therapy; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heparin; Hirudin Therapy; Hirudins; Humans; Platelet Aggregation Inhibitors; Recombinant Proteins; Renal Insufficiency; Stents; Thrombocytopenia; Tirofiban; Tyrosine | 2001 |
One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II.
Topics: Anticoagulants; Cardiopulmonary Bypass; Cardiovascular Diseases; Heparin; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine | 2001 |
Coagulation studies during therapeutic application of arvin.
Topics: Afibrinogenemia; Ancrod; Batroxobin; Blood Coagulation; Blood Coagulation Disorders; Blood Platelet Disorders; Blood Platelets; Drug Resistance; Endopeptidases; Fibrinogen; Fibrinolysis; Humans; Injections, Intravenous; Injections, Subcutaneous; Platelet Aggregation; Thrombin; Thrombocytopenia; Tyrosine | 1976 |
Hereditary tyrosinemia of chronic course without rickets and renal tubular dysfunction.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Amino Acids; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Heme; Heptanoates; Humans; Hydrolases; Male; Porphobilinogen Synthase; Thrombocytopenia; Tyrosine | 1990 |
[Tyrosinosis. Primary and secondary biochemical changes].
Topics: Age Factors; Amino Acid Metabolism, Inborn Errors; Child, Preschool; Diet Therapy; Glucagon; Glucose; Humans; Hypoglycemia; Infant; Infant, Newborn; Liver Function Tests; Methionine; Phenylalanine; Phosphates; Protein Biosynthesis; Rickets; Statistics as Topic; Thrombocytopenia; Time Factors; Tyrosine; Vomiting | 1972 |
May-Hegglin anomaly: a defect in megakaryocyte fragmentation?
Topics: Adenosine Diphosphate; Adolescent; Adult; Basophils; Blood Coagulation Tests; Blood Platelets; Cell Aggregation; Child; Cholesterol; Chromium Radioisotopes; Collagen; Eosinophils; Epinephrine; Female; Hematologic Diseases; Humans; Infant; Kinetics; Male; Megakaryocytes; Middle Aged; Neutrophils; Pedigree; Phospholipids; Platelet Adhesiveness; Prothrombin Time; Syndrome; Thrombocytopenia; Tyrosine | 1974 |